Home Blog Page 1756

Paperpal crosses 3 million users, strengthening global footprint as a trusted AI academic writing and research assistant

By
Advertorial Desk
-

DOVER, Del., Nov. 24, 2025 /PRNewswire/ — Paperpal, the AI writing and research assistant by Cactus Communications (CACTUS), surpasses three million users worldwide, marking a major milestone in its mission to empower students and researchers to write with clarity, precision, and integrity.

Paperpal’s rapid growth reflects its strong adoption in the academic community amid the rising need for reliable AI tools. The platform has tripled its user base in the past 18 months driven by its commitment to ethical AI that brings out the best in every user. With its deep understanding of academic writing, it has a proven ability to help users communicate research with confidence, while preserving their authentic voice.

Akhilesh Ayer, CEO, Cactus Communications, said, “As academia embraces AI, the focus remains on solutions that amplify human expertise. Crossing the three-million-user mark is more than a milestone for Paperpal; it is a testament to the growing trust in our vision to empower every academic with ethical, high-impact AI that advances scholarly communication.”

Nishchay Shah, Group CTO and EVP, Products & AI, Cactus Communications, added, “Researchers want more than generic AI; they seek intelligent, reliable partners that understand their academic journey. That’s what we offer. From polishing manuscripts and checking submission readiness to helping researchers find their scientific voice, Paperpal brings everything together in one intuitive platform. This milestone is not just about scale but about earning the trust of academics who see Paperpal as essential to their research journey.”

Paperpal encourages responsible authorship, supporting academics at every stage of research and writing. Its technology powers submission workflows for leading publishers, ensuring consistent quality, integrity, and efficiency. Students also rely on Paperpal to strengthen writing skills, improve clarity, and gain confidence in coursework and theses. With grammar checking, paraphrasing, plagiarism detection, AI summarization, and more, Paperpal helps users save time and focus on their research.

Academics consistently highlight Paperpal’s ease of use, comprehensive features, and accurate discipline-aware suggestions as top reasons for using the platform. Many say it helps them “think and write confidently without compromising quality” and “refine writing and grammar without losing their unique style.”

Paperpal has earned the trust of students, researchers, and institutions worldwide. It continues to grow as a platform that helps academics improve writing quality, communicate their science clearly, and overcome barriers to publication success.

For more details, please contact: Nidhi Amin
Cactus Communications
nidhi.amin@cactusglobal.com
newsroom@cactusglobal.com

 

DirectD and JCL Team Up to Expand Smartphone Accessibility in Malaysia and Advance Circular, Low-Carbon Practices

By
Advertorial Desk
-

KUALA LUMPUR, Malaysia, Nov. 24, 2025 /PRNewswire/ — DirectD, one of Malaysia’s largest multi-brand smartphone retailers, today announced a strategic partnership with JCL Credit Leasing (JCL), a Tokyo-headquartered financial services group, to expand accessibility to quality smartphones nationwide. The collaboration is set to remove key barriers to device ownership and simultaneously embed circular-economy principles to reduce e-waste and lifecycle carbon emissions.

DirectD and JCL unite to boost smartphone access sustainably. DirectD (left): Head of Affordability Program Norhayati Mohd Zain, Head of Product & Strategy (Apple) Ezwan Rais, CEO Amy Tan. JCL (right): Sales Manager Tan Yi Xin, Sales Leader Afzan D’Silva and Alicia Tye, Director Yutaka Tanimoto.
DirectD and JCL unite to boost smartphone access sustainably. DirectD (left): Head of Affordability Program Norhayati Mohd Zain, Head of Product & Strategy (Apple) Ezwan Rais, CEO Amy Tan. JCL (right): Sales Manager Tan Yi Xin, Sales Leader Afzan D’Silva and Alicia Tye, Director Yutaka Tanimoto.

By offering high-quality, reliable devices through accessible options, including flexible financing for owning, subscribing, or upgrading, the partnership aims to boost productivity across work and study for Malaysians from all segments of society, enhancing their daily lives.

“We’re excited to work with JCL to broaden access to reliable smartphones – an essential tool that powers income, learning, business transaction, and daily life,” said Amy Tan, CEO of DirectD. “Combining affordability with an easy upgrade or trade-in path keeps devices working longer, hence reducing our Scope 3 emissions and advancing our ESG agenda.”

“Digital inclusion and sustainability go hand in hand,” commented Mr. Yutaka Tanimoto, Director of JCL. “By pairing JCL’s consumer-finance expertise with DirectD’s nationwide footprint, we aim to help more Malaysians participate in the digital economy on transparent and manageable terms, supporting both individual productivity and environmental responsibility.”

Customers can look forward to lower financial hurdles and new ways to obtain higher quality devices across Malaysia, with special attention paid to underserved communities. To stretch budgets further, customers may trade in eligible devices for value toward their next phone. With circularity initiative, devices are routed to certified third-party partners for testing and refurbishment, then redeployed to extend lifecycles. Meanwhile, non-recoverable units are responsibly recycled to reduce e-waste and estimated lifecycle emissions.

DirectD has served more than one million consumers over the years and aims to deliver 30,000 devices to underserved communities through the partnership with JCL in 2026.

About DirectD

DirectD is a leading multi-brand smartphone retailer in Malaysia, offering nationwide retail coverage, trade-in, and upgrade services. DirectD champions reliable, high-quality devices through affordability programs that maximize customer value. Learn more at https://pakaidulu.directd.com.my. DirectD has a total of more than 20 stores nationwide. For locations and full listings, visit https://www.directd.com.my/shop-location

About JCL

JCL is a Tokyo-headquartered financial services group specializing in inclusive, and transparent that expand access to financial products and services across Asia.  Learn more at https://jcl.my/

 

Link Partners with Classic American Candy Brand Jelly Belly to Unleash “Jubilant Red Christmas” Magic

By
Advertorial Desk
-

Collaborates with Visa to offer ‘Jubilant Red Christmas Spending Rewards’ with Cash Rebates and Lucky Draw Entries

  • To mark its 20th anniversary, Link is launching a “Jubilant Red Christmas” campaign across 20 of its malls, featuring red-themed décor and optical illusion art installations, candy-themed photo spots and festive Jelly Belly scenes. 
  • Link is partnering with Visa for the first time to offer “Jubilant Red Christmas Spending Rewards”. Shoppers with spending of $2,800 or more can enjoy a 4.5% cash rebate and enter a lucky draw to win nearly $100,000 worth of cash vouchers.

HONG KONG, Nov. 24, 2025 /PRNewswire/ — Link Asset Management (Link) is collaborating with the classic American candy brand Jelly Belly to present the “Jubilant Red Christmas” campaign from 21 November 2025 to 11 January 2026, making this a sweet Christmas celebration filled with love and joy. In addition, to mark Link’s 20th anniversary this year, 20 Link malls have been decorated in dazzling red and feature optical illusion art installations to create a series of creative and playful photo spots and Christmas scenes featuring Mr Jelly Belly, the candy company’s official mascot.

Dazzling red-themed decorations adorn 20 of Link’s malls in the “Jubilant Red Christmas” cross-mall campaign.
Dazzling red-themed decorations adorn 20 of Link’s malls in the “Jubilant Red Christmas” cross-mall campaign.

Dazzling Red Photo Spots & Candy Elf Jumping Contest

During the event, 20 Link malls will turn into playful candy factories, themed in stunning red.

Mr Jelly Belly will surprise shoppers at various optical illusion art scenes. Lok Fu Plaza features a giant candy hot air balloon and a “Bean” train, Kai Tin Shopping Centre has a “Bean” racetrack and a giant capsule machine, and TKO Gateway is filled with romantic pink candies, creating a sweet atmosphere.

Kai Tin Shopping Centre will host a “Candy Elf Jumping Contest” on 3 January 2026, inviting kids to  dress as candy elves for the competition. Participation is free, and participants will receive generous gift packs. Winners will have a chance to win exclusive Jelly Belly boxsets and other prizes. The event will also feature exciting performances, and free candy will be distributed on-site, bringing the festive atmosphere to a climax.

“Jubilant Red Christmas Spending Rewards” with Cash Rebates of up to 4.5% & Lucky Draw Entries

This Christmas, Link is partnering with Visa to launch the “Jubilant Red Christmas Spending Rewards”.  During the promotion, customers with cumulative spending of $2,800 or more using Visa credit cards at participating tenants of the 20 Link malls will receive a $130 cash rebate. Eligible transactions also come with a lucky draw entry for a chance to win nearly $100,000 in mall cash vouchers. There are also numerous shopping discounts and offers for Visa cardholders – don’t miss out on these great deals!

“Jubilant Red Christmas Campaign“
Promotion Period: 21 November 2025 to 11 January 2026
Locations: 20 participating Link malls^

Link x Visa “Jubilant Red Christmas Spending Reward” 
Promotion Period: 21 November 2025 to 11 January 2026 Description: During the promotion period, customers with cumulative spending of $2,800 or more using registered Visa credit cards at participating tenants across all 20 participating Link malls will receive a cash rebate of up to $130 (available in limited quantities on a first-come, first-served basis while stock lasts). Each eligible Visa card transaction comes with one lucky draw entry.
Locations: 20 participating Link malls^
*Visa cardholders must register their cards to be eligible for this event
*Each cardholder may register multiple Visa cards for the event; each registered Visa credit card is eligible for the rebate reward twice during the event period 
*A minimum of $60 applies for each eligible card payment transaction
*Each registered Visa card can enjoy up to five lucky draw entries
Registration website: http://visaselectrewardhk.com/Link 

^20 participating Link malls include: T Town, Tin Shing Shopping Centre, Tin Chak Shopping Centre, Tin Yiu Plaza, Butterfly Plaza, Leung King Plaza, Choi Yuen Plaza, Tai Wo Plaza, Wo Che Plaza, Lok Fu Place, Temple Mall, Kai Tin Shopping Centre, Sau Mau Ping Shopping Centre, Lei Yue Mun Plaza, TKO Gateway, TKO Spot, Homantin Plaza, Tsz Wan Shan Shopping Centre, Fu Tung Plaza and Yat Tung Shopping Centre

Candy Elf Jumping Contest
Venue:  Event Area, 2/F, Kai Tin Shopping Centre, Lam Tin
Date: Saturday, 3 January 2026
Time: 2–4pm
Terms and conditions apply. Programme contents are subject to change without notice.
Event details: https://www.linkhk.com

Download images:
https://drive.google.com/drive/folders/1P-CH0SCOSH1CteX4s5J1C0EpDOWGzKaW?usp=sharing

–ENDS–

About Link Asset Management Limited

Link Asset Management Limited (Link) is a leading, independent, and fully integrated real estate investor and manager focusing on the APAC region. It manages Link Real Estate Investment Trust (Link REIT, Hong Kong stock code: 823), one of the largest REITs in Asia, and its real estate investment portfolio. Link also aims to leverage its investment management capabilities to serve as a trusted investment manager to capital partners through its business line, Link Real Estate Partners.

Building on its strong track record over almost two decades, Link targets to deliver resilient returns and growth to its unitholders. Link offers a “REIT plus” investment case through its strategic focus on diversifying the Link REIT Portfolio across geographies and asset classes in APAC and expanding its investment management business.

Link aspires to be the trusted partner in APAC real estate sector for unitholders, capital partners, tenants, and the wider communities it serves.

For more information about Link, please visit www.laml.com/en/. 

 

Harbour BioMed Advances Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Biotherapeutics in Oncology

By
Advertorial Desk
-

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Nov. 24, 2025 /PRNewswire/ — Harbour BioMed (“HBM” or the “Company”; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics for immunology and oncology, today announced an update and advancement of its global strategic collaboration with AstraZeneca, originally established in March 2025. The collaboration aims to discover and develop next-generation biotherapeutics, including antibody-drug conjugates (ADCs) and T cell engagers, leveraging the knowledge of both companies.

Under the terms of the agreement, AstraZeneca will continue to nominate discovery programs to Harbour BioMed each year over the next four years, reflecting the continued progress of the partnership, and will retain the option to license these programs for further development. Harbour BioMed will be eligible to receive option and option exercise fees, development and commercial milestone payments, plus tiered royalties on future net sales on such licensed programs. The economic terms are consistent with the financial framework established in March 2025.

Dr. Jingsong Wang, Founder, Chairman and CEO of Harbour BioMed, said: “We are pleased to advance our collaboration with AstraZeneca to develop next-generation biotherapeutics in oncology. Harbour BioMed has collaborated with AstraZeneca on multiple programs since 2022, and over time, the two parties have established a trusted and solid partnership. With our strong capabilities enabled by our proprietary antibody platforms, we are well positioned to support AstraZeneca in developing innovative biotherapeutics that can address significant unmet medical needs and improve patient outcomes globally.”

About Harbour BioMed

Harbour BioMed (HKEX: 02142) is a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology. The company is building a robust and differentiated pipeline through internal R&D capabilities, strategic global collaborations in co-discovery and co-development, and selective acquisitions.

Harbour BioMed’s proprietary antibody technology platform, Harbour Mice®, generates fully human monoclonal antibodies in both the conventional two heavy and two light chain (H2L2) format and the heavy chain-only (HCAb) format. Building upon HCAb antibodies, the HCAb-based immune cell engagers (HBICE®) bispecific antibody technology enables tumor-killing effects that traditional combination therapies cannot achieve. Additionally, the HCAb-based bispecific immune cell antagonist (HBICATM) technology empowers the development of innovative biologics for immunological and inflammatory diseases. By integrating Harbour Mice®, HBICE®, and HBICATM with a single B-cell cloning platform, Harbour BioMed has built a highly efficient and distinctive antibody discovery engine for developing next-generation therapeutic antibodies. For more information, please visit www.harbourbiomed.com.

Iinnofashion Expands Global Footprint with Participation in Japan Cosmetic Exhibition Following Entries into Russian Home Shopping and China’s Douyin

By
Advertorial Desk
-

SEOUL, South Korea, Nov. 24, 2025 /PRNewswire/ — Iinnofashion is accelerating its global beauty market strategy, following its participation in the 2025 Seoul Beauty Expo and its recent appearance at the Japan Cosmetic Exhibition held in Osaka this October.

The company’s flagship product, the All-in-One Toner Mask Bubble Booster, is gaining recognition as an innovative solution aligned with the rising trend of bubble-type beauty products. Unlike conventional liquid toners, it contains CICA ingredients and delivers multiple effects—soothing, brightening, nourishing, and mask-pack benefits—all in a single formula. Its ability to provide a comprehensive skincare routine with one product has made it especially appealing to busy modern consumers.

In Russia, Iinnofashion ‘s brand IINNO PURE COSME has already received strong customer response through its broadcast on the Leomax home shopping channel. In China, the company is currently in discussions for marketing collaborations through Douyin live commerce. Additionally, Iinnofashion is preparing to open a shop-in-shop targeting Chinese tourists at Jeju Dongmun Market this November, further expanding its global distribution network across both online and offline channels.

“We aim to strengthen our presence in key markets including Japan, Russia, and China, while also pursuing entry into Southeast Asia,” the company stated. “Our goal is to establish ourselves as a leading global brand representing K-beauty.”

SURFIRAN CO LTD Partners with Fermentation Master Insuk Jung for New Premium Product Development

By
Advertorial Desk
-

SEOUL, South Korea, Nov. 24, 2025 /PRNewswire/ — SURFIRAN CO LTD has announced a strategic collaboration with Master Artisan Insuk Jung, a leading figure in Korean traditional fermentation, to co-develop innovative saffron-based premium products.

The partnership aims to make saffron more familiar to Korean consumers by combining Master Jung’s fermentation expertise with SURFIRAN CO LTD’s specialization in top-quality saffron. Master Jung directly oversaw the entire production process, ensuring balanced fermentation and premium quality.

Industry observers note that this collaboration represents a rare fusion of world-class saffron and Korean fermentation craftsmanship—an effort expected to spark new trends in the domestic gourmet food sector.

A SURFIRAN CO LTD representative said, “Master Jung’s involvement elevated the flavor profile and authenticity of our products. We plan to continue developing items that blend saffron with Korean culinary culture.”

GenEditBio and ToolGen Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics

By
Advertorial Desk
-
  • Integrates ToolGen’s best-in-class CRISPR-Cas9 platform with GenEditBio’s industry-leading lipid nanoparticle (LNP) delivery technology
  • Pursues a “once-and-done” treatment paradigm for diseases with high unmet medical needs

SEOUL, South Korea and HONG KONG, Nov. 24, 2025 /PRNewswire/ — GenEditBio Limited (“GenEditBio”), a Hong Kong-headquartered clinical-stage biotechnology company specializing in novel deliveries, including lipid nanoparticle (LNP)-based delivery systems, announced today that it has entered into a strategic cross-license agreement with ToolGen Inc., a leading genome editing company based in Korea. Through this agreement, the companies will jointly advance the development of next-generation in vivo genome-editing therapeutics.

This collaboration brings together two essential and highly complementary technologies—ToolGen’s best-in-class CRISPR-Cas9 genome editing platform and GenEditBio’s industry-leading LNP delivery system. Together, these platforms enable a transformative approach to genome-editing therapeutics, aiming for a single-administration (“once-and-done”) treatment for diseases with significant unmet clinical needs.

The success of in vivo genome editing requires not only high-precision genome editing tools such as CRISPR-Cas9, but also a delivery system that ensures safe and efficient targeting of therapeutic cargo to the desired tissues. This collaboration leverages the respective strengths of both parties to generate strong synergies across the development pathway.

GenEditBio is developing GEB-200, an investigational in vivo genome-editing therapy targeting atherosclerotic cardiovascular disease (ASCVD). The company possesses proprietary LNP and other key delivery technologies optimized for the safe and efficient in vivo delivery of genome-editing agents such as CRISPR-Cas9. GEB-200 is designed to permanently lower plasma levels of lipoprotein(a), or Lp(a), a genetic risk factor affecting approximately 20% of the global population. The program has gained attention as a potential once-and-done alternative to existing chronic therapies in the cardiovascular field.

ToolGen and GenEditBio have been closely collaborating from the early development stages of GEB-200, combining their respective strengths to drive the program forward. The companies recently completed a successful proof-of-concept study in non-human primates (NHPs), which demonstrated effective target gene modulation and a favorable safety profile—marking a key milestone toward IND submission.

Looking ahead, ToolGen and GenEditBio plan to accelerate the regulatory path for GEB-200 by leveraging their integrated platform capabilities and to jointly explore global licensing opportunities under mutually agreed terms.

GenEditBio Co-founder and Chairman Prof. Zongli Zheng commented:

“GenEditBio and ToolGen share the same philosophy that ‘Together, We Are Stronger’ and a common goal of bringing safe and effective genome-editing therapies to patients with unmet medical needs. We are excited to enter this cross-license agreement with ToolGen to accelerate the development of GEB-200 beyond preclinical stage. The collaboration attests to our high-throughput LNP barcoding system that is highly predictive in clinical translation and ToolGen’s advanced CRISPR-Cas9 genome-editing technology.”

ToolGen CEO Dr. Jong Sang Ryu commented:

“Investor interest in gene-editing therapies targeting cardiovascular diseases is growing rapidly. Eli Lilly’s recent acquisition of Verve Therapeutics—whose pipeline includes an Lp(a)-targeted gene-editing program—for $1 billion upfront and up to $300 million in contingent value rights clearly reflects this trend. Through our strategic collaboration with GenEditBio, we aim to deliver a breakthrough in gene-editing treatment by combining ToolGen’s CRISPR expertise with GenEditBio’s advanced delivery technology, ultimately bringing transformative, once-and-done therapeutic options to patients worldwide.”

About ToolGen

ToolGen Inc. is a leading biotechnology company that leverages its foundational patent portfolio for CRISPR-Cas9 to drive research and business development in three core areas: IP Monetization, Therapeutics, and Crop Science. As a pivotal gene-editing technology, CRISPR-Cas9 enables the precise and selective modification of genetic information within cells, making it an extensively applied tool across the life sciences. The strength and value of ToolGen’s foundational CRISPR-Cas9 patents are demonstrated by their registration in 10 key jurisdictions, including the United States, Europe, China, Australia, and Japan. Furthermore, the technology’s competitive edge has been validated through out-licensing agreements with global industry leaders such as Monsanto and Thermo Fisher Scientific.

About GenEditBio

Established in 2021 and headquartered in Hong Kong, China, GenEditBio is a clinical-stage gene therapy start-up company with an overarching strategic goal of providing potentially curative, once-and-done and programmable in vivo genome editing-based therapeutic solutions (dubbed “DNA surgery”) with high safety profile, unmatched precision, and affordable access for genetic diseases with unmet needs. The Company’s core areas of focus include novel Cas nuclease discovery and safe and efficient cargo delivery utilizing lipid nanoparticle (LNP) and engineered protein delivery vehicle (PDV). We have research laboratories and supporting offices in Hong Kong, Beijing, and Boston. GenEditBio is financially backed by top-tier life science investors, including Qiming Venture Partners, Fangyuan Capital, Center Biotherapeutics, Lumosa Therapeutics, HKSTP Venture Fund, and others. For more information, please visit www.geneditbio.com.

ToolGen
Investors Contact
Ig.lee@toolgen.com

GenEditBio
Media Contact
geb.media@geneditbio.com

Investors Contact
bd@geneditbio.com

 

WORLD HYDROGEN EXPO 2025: THE WORLD’S LARGEST HYDROGEN INDUSTRY EVENT DEBUTS THIS DECEMBER

By
Advertorial Desk
-
  • WORLD HYDROGEN EXPO 2025 will take place from Wednesday, December 4 to Sunday, December 7 at KINTEX.
  • The event will showcase a full program, including H2 MEET, the world’s largest hydrogen exhibition, and the WHE 2025 Conference featuring global industry leaders.
  • The scale and stature of the event will be given greater international weight through coordination with the Hydrogen Council CEO Summit, a global coalition of hydrogen companies.

SEOUL, South Korea, Nov. 24, 2025 /PRNewswire/ — The WORLD HYDROGEN EXPO 2025 (“WHE 2025”), set to become the world’s largest hydrogen industry exhibition, will be held for four days from Wednesday, December 4, to Sunday, December 7, at KINTEX in Seoul, Korea.

The WHE 2025 Organizing Committee (the “Committee”) announced that it is integrating South Korea’s leading hydrogen industry exhibition, H2 MEET, held annually since 2020, with the nation’s largest hydrogen international conference, which took place last year on Hydrogen Day (November 2), under the unified global name World Hydrogen Expo, beginning this year.

  • Co-Chairmen of the Organizing Committee: Kang Nam-hoon, Chairman of the Korea Automobile & Mobility Association, and Kim Jae-hong, Chairman of the Korea Hydrogen Alliance.

As WHE 2025 launches as an integrated platform encompassing both an exhibition and a conference, the Committee aims to establish the foundation for South Korea’s emergence as a global hydrogen hub by providing a forum where global hydrogen industry companies and key leaders gather to share and discuss the importance of developing the hydrogen economy and strengthening global cooperation.

H2 MEET, which will be held from December 4 to 7 (four days) in KINTEX Exhibition Center 2 (Halls 7 and 8), is the flagship exhibition for the hydrogen industry, featuring companies, institutions, and organizations across the hydrogen production, storage/transport, and utilization sectors, and has been held annually since its first edition in 2020. Last year, the event was recognized as a world-class exhibition, drawing more than 320 companies from 24 countries and over 30,000 visitors. This year, the exhibition will extend through the weekend, giving general visitors a rare opportunity to experience hydrogen technologies firsthand.

From December 4 to 5 (two days), the newly reorganized WHE 2025 Conference, which updates the existing hydrogen conference, will be conducted across three distinct sessions.

The Leadership Address session will feature high-level government officials from key countries, including South Korea, Japan, Germany, the United States, Australia, and Malaysia, who will share global policy priorities as they present their national strategies for the transition to clean hydrogen.

In the Hydrogen Deep Dive session, world-leading companies and industry experts will deliver in-depth presentations and discussions on key issues such as the hydrogen supply chain, technology commercialization, international standards and outline practical solutions.

The Country Day session will consist of technical seminars hosted by the national pavilions of participating countries, focusing on each country’s hydrogen industry policies and technology trends.

In addition to the exhibition and conference, several side events will be held concurrently during the event period.

The Global Partnership Meeting for the Hydrogen Industry (December 4–7), co-organized by the Committee and KOTRA, will support business matching between domestic hydrogen companies and global buyers to facilitate the international expansion of South Korean firms during the event.

The 6th Korea–Germany Hydrogen Conference (December 3) is expected to feature technical exchange between experts from both countries across five major sectors: hydrogen policy, production, storage, utilization, and safety.

Furthermore, the 8th General Assembly (December 5) of the Global Hydrogen Industrial Associations Alliance (GHIAA*), involving hydrogen organizations from 26 countries, is expected to serve as an important milestone in strengthening South Korea’s role as a hub for global hydrogen cooperation.

  • GHIAA: The Global Hydrogen Industrial Associations Alliance (GHIAA) is an international coalition founded to promote the transition to a clean hydrogen economy and global cooperation and currently includes 26 member countries.

The event is also being scheduled in December to align with the Hydrogen Council CEO Summit (December 2–4), where leaders of global hydrogen companies will convene, and the participating hydrogen company leaders will engage with domestic companies and organizations across the event lineup, including the opening ceremony, exhibition, conference, and business meetings.

  • Hydrogen Council: A consortium composed of more than 150 global hydrogen companies.

Kang Nam-hoon, Chairman of the WHE Organizing Committee, stated, “As we prepare for this event under the new name World Hydrogen Expo, aiming for it to become the world’s premier and largest hydrogen exhibition, we are working to attract top-tier speakers, senior government officials from around the world, and leading global hydrogen companies,” adding, “We will strive for a successful event that can offer a clear overview of global hydrogen industry trends and contribute to strengthening the foundation for global cooperation across the entire industry.” More detailed information is available on the official website (www.world-hydrogen-expo.com).

1...1,7551,7561,757...6,495Page 1,756 of 6,495